Connable Office Inc’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $240K | Sell |
14,266
-1,494
| -9% | -$26.7K | 0.02% | 198 |
|
|
2025
Q4 | $253K | Buy |
+15,760
| New | +$235K | 0.02% | 209 |
|
|
2025
Q3 | – | Sell |
-16,445
| Closed | -$189K | – | 225 |
|
|
2025
Q2 | $189K | Hold |
16,445
| – | – | 0.02% | 217 |
|
|
2025
Q1 | $247K | Hold |
16,445
| – | – | 0.03% | 190 |
|
|
2024
Q4 | $285K | Sell |
16,445
-348
| -2% | -$6.71K | 0.03% | 194 |
|
|
2024
Q3 | $311K | Buy |
16,793
+2,569
| +18% | +$51.6K | 0.03% | 188 |
|
|
2024
Q2 | $289K | Hold |
14,224
| – | – | 0.03% | 189 |
|
|
2024
Q1 | $243K | Buy |
14,224
+296
| +2% | +$4.66K | 0.03% | 191 |
|
|
2023
Q4 | $246K | Hold |
13,928
| – | – | 0.03% | 186 |
|
|
2023
Q3 | $334K | Hold |
13,928
| – | – | 0.05% | 151 |
|
|
2023
Q2 | $324K | Buy |
+13,928
| New | +$315K | 0.04% | 164 |
|
|
2019
Q3 | – | Sell |
-3,836
| Closed | -$201K | – | 182 |
|
|
2019
Q2 | $201K | Buy |
+3,836
| New | +$225K | 0.04% | 171 |
|
|
2018
Q4 | – | Sell |
-9,663
| Closed | -$1.12M | – | 160 |
|
|
2018
Q3 | $1.12M | Hold |
9,663
| – | – | 0.21% | 79 |
|
|
2018
Q2 | $1.22M | Sell |
9,663
-483
| -5% | -$58.8K | 0.25% | 72 |
|
|
2018
Q1 | $1.1M | Buy |
10,146
+477
| +5% | +$52.8K | 0.22% | 79 |
|
|
2017
Q4 | $1.06M | Sell |
9,669
-1,421
| -13% | -$142K | 0.21% | 77 |
|
|
2017
Q3 | $1.09M | Buy |
11,090
+122
| +1% | +$11.8K | 0.22% | 76 |
|
|
2017
Q2 | $1.11M | Buy |
10,968
+9,162
| +507% | +$988K | 0.24% | 78 |
|
|
2017
Q1 | $209K | Sell |
1,806
-2,514
| -58% | -$292K | 0.05% | 165 |
|
|
2016
Q4 | $519K | Sell |
4,320
-13,120
| -75% | -$1.45M | 0.12% | 105 |
|
|
2016
Q3 | $1.96M | Buy |
17,440
+2,160
| +14% | +$249K | 0.47% | 57 |
|
|
2016
Q2 | $1.89M | Sell |
15,280
-1,168
| -7% | -$141K | 0.53% | 52 |
|
|
2016
Q1 | $1.85M | Sell |
16,448
-73
| -0.4% | -$7.58K | 0.51% | 56 |
|
|
2015
Q4 | $1.8M | Sell |
16,521
-138
| -0.8% | -$15.8K | 0.52% | 55 |
|
|
2015
Q3 | $1.66M | Sell |
16,659
-1,063
| -6% | -$116K | 0.49% | 56 |
|
|
2015
Q2 | $2.02M | Buy |
17,722
+11,237
| +173% | +$1.36M | 0.54% | 55 |
|
|
2015
Q1 | $678K | Sell |
6,485
-275
| -4% | -$29.3K | 0.17% | 74 |
|
|
2014
Q4 | $813K | Sell |
6,760
-280
| -4% | -$36.8K | 0.22% | 70 |
|
|
2014
Q3 | $1.03M | Sell |
7,040
-20
| -0.3% | -$3.09K | 0.27% | 67 |
|
|
2014
Q2 | $1.18M | Sell |
7,060
-735
| -9% | -$131K | 0.3% | 65 |
|
|
2014
Q1 | $1.55M | Sell |
7,795
-250
| -3% | -$47.2K | 0.42% | 59 |
|
|
2013
Q4 | $1.54M | Sell |
8,045
-1,589
| -16% | -$296K | 0.42% | 60 |
|
|
2013
Q3 | $1.63M | Buy |
9,634
+206
| +2% | +$32K | 0.46% | 55 |
|
|
2013
Q2 | $1.43M | Buy |
+9,428
| New | +$1.34M | 0.41% | 58 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Connable Office Inc's CLB Position: Q1 2026 in Review
Connable Office Inc reduced its Core Laboratories (CLB) stake by 9.5% in Q1 2026, selling an estimated $26.7K and leaving 14,266 shares worth $240K. The position accounts for 0.02% of the portfolio, ranked #198.
Connable Office Inc first reported a position in CLB in Q2 2013 and has held it in 34 quarters since. The position peaked at $2.02M in Q2 2015. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Connable Office Inc held 14,266 shares of Core Laboratories worth $240K as of Q1 2026.
- Connable Office Inc sold 1,494 Core Laboratories shares in Q1 2026, an estimated $26.7K.
- Core Laboratories made up 0.02% of Connable Office Inc's portfolio in Q1 2026, its #198 holding.
- Connable Office Inc first reported a position in Core Laboratories in Q2 2013 and has held it in 34 quarters since.
- Connable Office Inc's Core Laboratories position peaked at $2.02M in Q2 2015.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Connable Office Inc's 13F filing for Q1 2026, filed 29 Apr 2026.